Growth Metrics

Amphastar Pharmaceuticals (AMPH) EPS (Weighted Average and Diluted): 2013-2025

Historic EPS (Weighted Average and Diluted) for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to $0.37.

  • Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) fell 52.56% to $0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.26, marking a year-over-year decrease of 24.92%. This contributed to the annual value of $3.06 for FY2024, which is 17.69% up from last year.
  • Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $0.37 in Q3 2025, which was down 42.19% from $0.64 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $0.91 for Q3 2023, and its period low was $0.10 during Q1 2021.
  • For the 3-year period, Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around $0.65, with its median value being $0.69 (2023).
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) soared by 637.50% in 2021, and later tumbled by 52.56% in 2025.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.40 in 2021, then soared by 62.50% to $0.65 in 2022, then climbed by 6.15% to $0.69 in 2023, then grew by 7.25% to $0.74 in 2024, then crashed by 52.56% to $0.37 in 2025.
  • Its last three reported values are $0.37 in Q3 2025, $0.64 for Q2 2025, and $0.51 during Q1 2025.